Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ФГБОУ ВО «Кубанский государственный медицинский университет», Краснодар, Россия; 2ГБУЗ «Краевая клиническая больница №2», Краснодар, Россия
Список исп. литературыСкрыть список 1. Покровский В.М. Физиология человека. М.: Медицина, 2011. [Pokrovskii VM. Fiziologiya cheloveka. Moscow: Meditsina, 2011 (in Russian)]. 2. Елисеева Л.Н., Самородская Н.А. Многоуровневый анализ нарушений регуляторных механизмов как основа выбора индивидуальной антигипертензивной терапии у больных гипертонической болезнью (часть II). Оптимизация выбора антигипертензивной терапии с учетом многоуровневого анализа нарушений механизмов регуляции артериального давления. Медицинский вестник Северного Кавказа 2020; 15 (2): 234–40. [Yeliseyeva L, Samorodskaya NA. Multilevel analysis of regulatory mechanism disorders as a principle of choice for individual antihypertensive therapy in patients with hypertension (Part II). Optimization of antihypertensive therapy choice taking into account the multilevel analysis of. Med news North Caucasus 2020; 15 (2): 234–40 (in Russian)]. DOI: 10.14300/mnnc.2020.15055 3. Физиология человека и животных. Под ред. Д.Л. Теплого, Ю.В. Нестеров, Е.В. Курьяновой и др. Астрахань: Издательский дом «Астраханский университет», 2017. 336 с. [Fiziologiya cheloveka i zhivotnykh Ed by Teplyi DL, Nesterov YuV, Kur'yanova EV et al. Astrakhan': Izdatel'skii dom «Astrakhanskii universitet», 2017. 336 p (in Russian)]. 4. Ngene NC, Moodley J. Physiology of blood pressure relevant to managing hypertension in pregnancy. J Matern Neonatal Med 2019; 32 (8): 1368–377. DOI: 10.1080/14767058.2017.1404569 5. Meah VL, Cockcroft JR, Backx K et al. Cardiac output and related haemodynamics during pregnancy: a series of meta-analyses. Heart 2016; 102 (7): 518–26. DOI: 10.1136/heartjnl-2015-308476 6. Государственный реестр лекарственных средств. [Gosudarstvennyi reestr lekarstvennykh sredstv. (in Russian)]. Доступно по: grls.rosminzdrav.ru State Register of Medicines: grls.rosminzdrav.ru 7 Franklin SS, Lopez VA, Wong ND et al. Single Versus Combined Blood Pressure Components and Risk for Cardiovascular Disease. Circulation 2009; 119 (2): 243–50. DOI: 10.1161/CIRCULATIONAHA. 108.797936 8 Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. J Hypertens 2018; 36 (10): 1953–2041. DOI: 10.1097/HJH.0000000000001940 9. Кобалава Ж.Д., Конради А.О., Недогода С.В. и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал 2020; 25 (3): 149–218. [Kobalava ZD, Konradi AO, Nedogoda SV et al. Arterial hypertension in adults. Clinical guidelines 2020. Russ J Cardiol 2020; 25 (3): 149–218. (in Russian)]. DOI: 10.15829/1560-4071-2020-3-3786 10. Lumbers ER, Pringle KG. Roles of the circulating renin-angiotensin-aldosterone system in human pregnancy. Am J Physiol Integr Comp Physiol 2014; 306 (2): R91–R101. DOI: 10.1152/ajpregu.00034.2013 11. Williams B, Mancia G, Spiering W et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018; 36 (12): 2284–309. DOI: 10.1097/HJH.0000000000001961 12. Easterling T, Mundle S, Bracken H et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet 2019; 394 (10203): 1011–21. DOI: 10.1016/S0140-6736(19)31282-6 13. Finer LB, Zolna MR. Declines in Unintended Pregnancy in the United States, 2008–2011. N Engl J Med 2016; 374 (9): 843–52. DOI: 10.1056/NEJMsa1506575 14. Editorial A. Diagnosis and treatment of cardiovascular diseases during pregnancy 2018. National guidelines. Russ J Cardiol 2018; 3: 91–134. DOI: 10.15829/1560-4071-2018-3-91-134 15. Чазова И.Е., Мартынюк Т.В. Диуретики в составе комбинированной антигипертензивной терапии: фокус на прогноз. Системные гипертензии 2016; 13 (2): 6–10. [Chazova IE, Martynyuk TV. Diuretiki v sostave kombinirovannoi antigipertenzivnoi terapii: fokus na prognoz. Sistemnye gipertenzii 2016; 13 (2): 6–10 (in Russian)]. 16. Барсуков А.В., Васильева И.А., Сеидова А.Ю. Место тиазидных и тиазидоподобных диуретиков в современной гипертензиологии. Клиническая патофизиология 2019; 25 (3): 11–24. [Barsukov AV, Vasil'eva IA, Seidova AYu. Mesto tiazidnykh i tiazidopodobnykh diuretikovv sovremennoi gipertenziologii. Klinicheskaya patofiziologiya 2019; 25 (3): 11–24 (in Russian)]. 17. Butalia S, Audibert F, Côté A-M et al. Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy. Can J Cardiol 2018; 34 (5): 526–31. DOI: 10.1016/j.cjca.2018.02.021 18. ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstet Gynecol 2019; 133 (1): e26–e50. DOI: 10.1097/AOG. 0000000000003020 19. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39 (34): 3165–241. DOI: 10.1093/eurheartj/ehy340 20. Lowe SA, Bowyer L, Lust K et al. The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014. Aust New Zeal J Obstet Gynaecol 2015; 55 (1): 11–6. DOI: 10.1111/ajo.12253 21. Redman CWG. Hypertension in pregnancy: the NICE guidelines. Heart 2011; 97 (23): 1967–9. DOI: 10.1136/heartjnl-2011-300949 22. Churchill D, Beevers GDG, Meher S, Rhodes C. Diuretics for preventing pre-eclampsia. Cochrane Database Syst Rev 2007; 1. DOI: 10.1002/14651858.CD004451.pub2 23. Finnerty FA. Lowering the Perinatal Mortality and the Prematurity Rate. JAMA 1966; 195 (6): 429. DOI: 10.1001/jama.1966. 03100060069020 24. Hays PM, Cruikshank DP, Dunn LJ. Plasma volume determination in normal and preeclamptic pregnancies. Am J Obstet Gynecol 1985; 151 (7): 958–66. DOI: 10.1016/0002-9378(85)90675-1 25. Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol 1984; 150 (7): 831–5. DOI: 10.1016/0002-9378(84)90458-7 26. Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy. BMJ 1985; 290 (6461): 17–23. DOI: 10.1136/ bmj.290.6461.17 27. Bateman BT, Patorno E, Desai RJ et al. Late Pregnancy Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia. Pediatrics 2016; 138 (3): e20160731. DOI: 10.1542/peds.2016-0731 28. Bateman BT, Heide-Jørgensen U, Einarsdóttir K et al. β-Blocker Use in Pregnancy and the Risk for Congenital Malformations. Ann Intern Med 2018; 169 (10): 665. DOI: 10.7326/M18-0338 29. Cockburn J, Ounsted M, Moar VA, Redman CWG. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982; 319 (8273): 647–9. DOI: 10.1016/S0140-6736(82)92202-4 30. Hoeltzenbein M, Beck E, Fietz A-K et al. Pregnancy Outcome After First Trimester Use of Methyldopa. Hypertension 2017; 70 (1): 201–8. DOI: 10.1161/HYPERTENSIONAHA.117.09110 31. Tranquilli AL, Dekker G, Magee L et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens An Int J Women’s Cardiovasc Heal 2014; 4 (2): 97–104. DOI: 10.1016/ j.preghy.2014.02.001 32. Brown MA, Magee LA, Kenny LC et al. Hypertensive Disorders of Pregnancy. Hypertension 2018; 72 (1): 24-43. DOI: 10.1161/HYPERTENSIONAHA.117.10803 33. Abalos E, Duley L, Steyn DW, Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2018; 10. DOI: 10.1002/14651858.CD002252.pub4 34. Magee L, Dadelszen P, Singer J et al. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG An Int J Obstet Gynaecol 2016; 123 (7): 1143–51. DOI: 10.1111/1471-0528.13569 35. Xie R, Guo Y, Krewski D et al. Association between labetalol use for hypertension in pregnancy and adverse infant outcomes. Eur J Obstet Gynecol Reprod Biol 2014; 175: 124–8. DOI: 10.1016/j.ejogrb. 2014.01.019 36. Meah VL, Cockcroft JR, Backx K et al. Cardiac output and related haemodynamics during pregnancy: a series of meta-analyses. Heart 2016; 102 (7): 518–26. DOI: 10.1136/heartjnl-2015-308476 37. Berkane N, Liere P, Oudinet JP et al. From Pregnancy to Preeclampsia: A Key Role for Estrogens. Endocr Rev 2017; 38 (2): 123–44. DOI: 10.1210/er.2016-1065 38. Conrad KP. Maternal vasodilation in pregnancy: the emerging role of relaxin. Am J Physiol Integr Comp Physiol 2011; 301 (2): R267–75. DOI: 10.1152/ajpregu.00156.2011 39. Kodogo V, Azibani F, Sliwa K. Role of pregnancy hormones and hormonal interaction on the maternal cardiovascular system: a literature review. Clin Res Cardiol 2019; 108 (8): 831–46. DOI: 10.1007/s00392-019-01441-x 40. Shi D-D, Wang Y, Guo J-J, et al. Vitamin D Enhances Efficacy of Oral Nifedipine in Treating Preeclampsia with Severe Features: A Double Blinded, Placebo-Controlled and Randomized Clinical Trial. Front Pharmacol 2017; 8. DOI: 10.3389/fphar.2017.00865 41. Magee LA, Schick B, Donnenfeld AE et al. The safety of calcium channel blockers in human pregnancy: A prospective, multicenter cohort study. Am J Obstet Gynecol 1996; 174 (3): 823–8. DOI: 10.1016/S0002-9378(96)70307-1 42. Ahn HK, Nava-Ocampo AA, Han JY et al. Exposure to Amlodipine in the First Trimester of Pregnancy and During Breastfeeding. Hypertens Pregnancy 2007; 26 (2): 179–87. DOI: 10.1080/ 10641950701204554 43. Vigil-De Gracia P, Dominguez L, Solis A. Management of chronic hypertension during pregnancy with furosemide, amlodipine or aspirin: a pilot clinical trial. J Matern Neonatal Med 2014; 27 (13): 1291–4. DOI: 10.3109/14767058.2013.852180